The Kraft Heinz Company Free cash flow decreased by 34.6% to $766.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 58.9%, from $482.00M to $766.00M. Over 4 years (FY 2021 to FY 2025), Free cash flow shows a downward trend with a -4.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flow| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.02B | $195.00M | $2.67B | $272.00M | $81.00M | $532.00M | $668.00M | $220.00M | $856.00M | $765.00M | $1.12B | $477.00M | $693.00M | $849.00M | $1.14B | $482.00M | $1.02B | $986.00M | $1.17B | $766.00M |
| QoQ Change | — | -80.8% | >999% | -89.8% | -70.2% | +556.8% | +25.6% | -67.1% | +289.1% | -10.6% | +46.7% | -57.5% | +45.3% | +22.5% | +34.4% | -57.8% | +112.0% | -3.5% | +18.8% | -34.6% |
| YoY Change | — | — | — | — | -92.0% | +172.8% | -74.9% | -19.1% | +956.8% | +43.8% | +68.0% | +116.8% | -19.0% | +11.0% | +1.7% | +1.0% | +47.5% | +16.1% | +2.6% | +58.9% |